Whatever Happened to Tilray (NASDAQ:TLRY)?

Tilray Inc (NASDAQ:TLRY) was one of the stars of last year’s marijuana madness. During the rally kicked off by Canopy Growth Corp’s (TSX:WEED)(NYSE:CGC) $5 billion acquisition, Tilray actually briefly eclipsed Canopy itself, going on a 750% rally that sent its market cap to unprecedented levels. At the time, there was a lot of hype surrounding the company, a recent IPO…

Read More

Why Cronos Group (TSX:CRON) Declined Despite Posting a Huge Profit in Q1

Cronos Group Inc  (TSX:CRON)(NASDAQ:CRON) released its quarterly results last week, which showed sales more than doubling from the previous year. The company also recorded a massive $428 million profit during the quarter as well. However, the stock still declined 7% last week, leaving some investors scratching their heads. Why is the stock down? Although Cronos saw a big increase in…

Read More

Tokenized Securities Exchanges Get Ready to Rumble

blockchain

story via BreakMag.com by Robert England The race is on to be the NASDAQ of blockchain. As the market for tokenized securities begins to take shape, U.S. trading platforms are seeking first mover advantage. The winner hopes to become the primary destination for investors and traders to buy and sell tokens for equity, debt, and other security instruments. Evangelists see…

Read More

Alliqua BioMedical, Inc. (NASDAQ: ALQA) Skyrockets 168% After Announcing Plans to Spin-Off and Merger Contract Manufacturing Business With TO Pharmaceuticals, LLC

Alliqua BioMedical, Inc. (NASDAQ: ALQA) operates as a custom manufacturer within the medical device, cosmetics, OTC markets. Shares of the medical manufacturer are skyrocketing 168.08%, through early trading on Wednesday, November 28, 2018. Over the past three months, Alliqua BioMedical, Inc. has seen average daily volume of 13,278 shares. However, volume of 15.06 million shares or dollar volume of $59.94…

Read More